Las Vegas, NV -- (SBWIRE) -- 10/21/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Apollo Investment Corp. (NASDAQ:AINV), Fifth Street Finance Corp. (NASDAQ:FSC), Maxim Integrated Products Inc. (NASDAQ:MXIM), Rexahn Pharmaceuticals, Inc. (NYSEMKT: RNN)
Apollo Investment Corp. (NASDAQ:AINV) managed to keep its gain at 0.77% on below -normal volume of 1.54M shares. The stock settled at $8.49 after floating in a range of $8.42 to $8.50. Its latest price has reached market capitalization of $1.91 billion. Its 52-week range has been $7.21 to $9.08. Apollo Investment Corporation is business development company and operates as a closed-end management investment company.
For How Long AINV will fight for Profitability? Read This Trend Analysis report
Fifth Street Finance Corp. (NASDAQ:FSC) traded up on a volume of 1.54 million, lower than its standard daily volume. Shares have dropped0.49% to $10.20. Over the last twelve months, the stock has lost-4.67% and faced a worst price of $9.66. Fifth Street Finance Corp. is a business development company specializing in investments in middle market, bridge financing, first and second lien debt financing, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, and management buyouts in small and mid-sized companies.
For How Long FSC’s Gloss will Attract Investors? Find out via this report
Maxim Integrated Products Inc. (NASDAQ:MXIM) settled 1.09% higher at $29.97 on below -normal volume of 1.53M shares during the last trading day. The stock has its 12-month high at $33.67 and 52-week low price was $26.13. It traded in a range of $29.57 to $30 during the last trading day. Maxim Integrated Products, Inc. designs, develops, manufactures, and markets various linear and mixed-signal integrated circuits worldwide.
Why Should Investors Buy MXIM After the Recent Fall? Just Go Here and Find Out
In the last trading session, Rexahn Pharmaceuticals, Inc. (NYSEMKT: RNN) was down on low volume, trading at a volume of 1.53M shares versus its average daily volume of 1.63 million shares. At $0.477, the stock has attained market capitalization of $56.91 .million. Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for cancer, central nervous system disorders, sexual dysfunction, and other medical needs.
Why Should Investors Buy RNN After the Recent Fall? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)